Patients with MDD have been reported to have cortisol hypersecretion11, reduced glucocorticoid receptor mRNA expression, and decreased glucocorticoid-induced inhibitory feedback to the HPA-axis12. This evidence concerns the gene NR3C1 and major depressive disorder.